High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9.1M
$9,090,605
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2026-04-01
$60,029
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2026-04-01 | $60,029 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 Sell
2026-03-20
$313,038x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 Sell
|
2026-03-20 | $313,038x2 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Other
2026-03-19
$2,989
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Other
|
2026-03-19 | $2,989 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2026-03-19
$43,815
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2026-03-19 | $43,815 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-18
$145,063x3
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-18 | $145,063x3 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-18
$60,526x3
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-18 | $60,526x3 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-18 | $74,663x3 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2026-03-18
$209,569x3
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2026-03-18 | $209,569x3 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-17
$140,838x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-17 | $140,838x2 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-17
$58,785x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-17 | $58,785x2 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-17 | $72,482x2 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2026-03-17
$203,451x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2026-03-17 | $203,451x2 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -12.5%
|
2026-03-13 | $22,264 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Krainer Adrian R.
• Director
10b5-1 SellΔOwn -10.5%
2026-03-10
$1,320,964Large
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -10.5%
|
2026-03-10 | $1,320,964Large | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Chair
Other
|
2026-03-10 | $32,945 | M | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Chair
10b5-1 SellΔOwn -12.2%
|
2026-03-10 | $174,214 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-02 | $286,715 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-05
$274,898x3
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-05 | $274,898x3 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-05 | $267,761x3 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-05
$114,762x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-05 | $114,762x2 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-04
$31,425x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-04 | $31,425x2 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-04 | $199,197x2 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-04
$52,353x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-04 | $52,353x2 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-03
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-03
$70,245x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-03 | $70,245x2 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-03 | $32,793x2 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Equity Compensation
2025-12-03
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-03
$61,725x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-03 | $61,725x2 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-02
$68,023x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-02 | $68,023x2 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-02 | $31,748x2 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-02
$59,743x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-02 | $59,743x2 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-01
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Equity Compensation
2025-12-01
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Krainer Adrian R.
• Director
10b5-1 SellΔOwn -11.1%
2025-11-24
$1,202,719Large
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -11.1%
|
2025-11-24 | $1,202,719Large | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Krainer Adrian R.
• Director
10b5-1 Sell
2025-11-14
$1,092,058Largex2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-11-14 | $1,092,058Largex2 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2025-11-03
$152,566x4
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2025-11-03 | $152,566x4 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Other
|
2025-10-08 | $15,000 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Kaye Edward M. MD
• Director
10b5-1 SellΔOwn -33.7%
2025-10-08
$750,000
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -33.7%
|
2025-10-08 | $750,000 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Other
2025-10-03
$91,500
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Other
|
2025-10-03 | $91,500 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
2025-10-03
$250,650
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
|
2025-10-03 | $250,650 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Kaye Edward M. MD
• Director
10b5-1 SellΔOwn -46.4%
2025-10-03
$1,065,206Large
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -46.4%
|
2025-10-03 | $1,065,206Large | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.9%
2025-10-01
$126,316
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.9%
|
2025-10-01 | $126,316 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Equity Compensation
|
2024-12-01 | $0 | M | Form 4 |